IMAX (IMAX) to Release Earnings on Thursday

IMAX (NYSE:IMAX) will likely be announcing its Q2 2026 results before the market opens on Thursday, July 23rd. Analysts expect IMAX to post earnings of $0.28 per share and revenue of $95.0070 million for the quarter. Investors may review the information on the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Thursday, July 23, 2026 at 8:30 AM ET.

IMAX (NYSE:IMAX) last released its earnings results on Thursday, April 30th. The company reported $0.17 EPS for the quarter, beating the consensus estimate of $0.15 by $0.02. IMAX had a return on equity of 13.61% and a net margin of 9.08%.The firm had revenue of $81.38 million during the quarter, compared to analyst estimates of $79.82 million. During the same period in the prior year, the firm posted $0.13 earnings per share. The business’s quarterly revenue was down 6.1% compared to the same quarter last year. On average, analysts expect IMAX to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

IMAX Trading Down 1.5%

NYSE IMAX opened at $38.67 on Tuesday. The business’s 50-day moving average price is $39.41 and its 200 day moving average price is $37.92. IMAX has a twelve month low of $24.20 and a twelve month high of $45.52. The company has a market capitalization of $2.13 billion, a PE ratio of 59.50, a price-to-earnings-growth ratio of 1.44 and a beta of 0.37.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on IMAX. Benchmark reissued a “buy” rating on shares of IMAX in a research note on Monday, June 22nd. Wells Fargo & Company reaffirmed an “equal weight” rating and issued a $41.00 target price (down from $47.00) on shares of IMAX in a research report on Thursday. Seaport Research Partners reiterated a “buy” rating and issued a $50.00 target price on shares of IMAX in a report on Wednesday, June 24th. Weiss Ratings raised IMAX from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday. Finally, JPMorgan Chase & Co. dropped their price target on IMAX from $48.00 to $47.00 and set an “overweight” rating for the company in a research note on Friday, May 1st. Nine investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, IMAX presently has an average rating of “Moderate Buy” and a consensus price target of $47.30.

Key Stories Impacting IMAX

Here are the key news stories impacting IMAX this week:

• Positive Sentiment: Rosenblatt Securities reaffirmed its Buy rating on IMAX and lifted its price target to $47, implying meaningful upside from recent trading levels. Benzinga article
• Positive Sentiment: CEO Richard Gelfond highlighted the success of The Odyssey and IMAX’s movie technology, reinforcing the company’s positioning as the premium venue for big-event films. YouTube interview
• Positive Sentiment: Multiple media reports show strong consumer interest in The Odyssey on IMAX 70mm, including sold-out/limited screenings and fans seeking out theaters that can show the film as intended, which could support near-term box office and IMAX format demand. Arizona theater article
• Positive Sentiment: Coverage emphasizing where to find The Odyssey in IMAX 70mm and early viewer reactions may keep IMAX in the spotlight and drive awareness of its premium format. Yahoo Entertainment article
• Negative Sentiment: Wells Fargo cut IMAX to Equal Weight, a cautious move that may have added pressure to the shares and signaled more limited upside in the near term. American Banking News article

Insider Transactions at IMAX

In other news, CEO Richard L. Gelfond sold 8,943 shares of the company’s stock in a transaction dated Monday, April 27th. The stock was sold at an average price of $37.33, for a total value of $333,842.19. Following the completion of the sale, the chief executive officer owned 765,002 shares of the company’s stock, valued at $28,557,524.66. This represents a 1.16% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 20.55% of the company’s stock.

Hedge Funds Weigh In On IMAX

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Amundi purchased a new stake in shares of IMAX during the fourth quarter worth about $213,000. Magnetar Financial LLC acquired a new position in shares of IMAX in the fourth quarter worth about $222,000. Arax Advisory Partners boosted its holdings in IMAX by 49.7% in the fourth quarter. Arax Advisory Partners now owns 4,163 shares of the company’s stock valued at $154,000 after purchasing an additional 1,383 shares during the last quarter. Picton Mahoney Asset Management acquired a new stake in IMAX during the 4th quarter valued at approximately $209,000. Finally, Russell Investments Group Ltd. increased its holdings in IMAX by 505.0% during the 3rd quarter. Russell Investments Group Ltd. now owns 4,683 shares of the company’s stock worth $153,000 after purchasing an additional 3,909 shares during the last quarter. Hedge funds and other institutional investors own 93.51% of the company’s stock.

About IMAX

IMAX Corporation is a global leader in immersive entertainment technologies, specializing in the design, manufacture and distribution of high-resolution cameras, projectors, and proprietary software solutions that enhance both film production and theatrical exhibition. The company licenses its premium large-format system to theatre owners and filmmakers around the world, enabling audiences to experience movies with greater clarity, scale and sound fidelity. IMAX also offers turnkey theatre development services, assisting cinema operators with auditorium design, installation and custom branding to optimize the customer experience.

Founded in 1967 and headquartered in Mississauga, Ontario, IMAX has built a reputation for pioneering film-format innovations, including its patented dual 15-perforation, 70-millimeter projection system.